EDAS Healthcare
Instant Detection of Respiratory Infectious Diseases and COVID-19
Company Overview
Snapshot
Founded in September 2018 by Guy Livne and Gal Almogy, EDAS Healthcare operated with 1–10 employees. The company secured $60K in total capital across one funding round. In February 2020, EDAS Healthcare received a grant from EU Horizon 2020.
Business overview
EDAS Healthcare specializes in developing AI-driven solutions for the instant detection of respiratory infectious diseases, including COVID-19. Its core technology leverages artificial intelligence to identify specific infecting pathogens using only anonymous patient demographics, eliminating the need for physical tests or equipment. The company's solution, EDAS, aims to enhance treatment quality, reduce primary care costs, and decrease antibiotic overuse, while enabling diagnosis through telemedicine. EDAS Healthcare operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Medical Decision Support, Digital Medical Diagnostics, and Medical Devices, serving markets in Europe and North America.
Strategic signal
In September 2020, EDAS Healthcare's AI technology gained attention for its ability to diagnose COVID-19 based on patient demographics, highlighting the potential of non-invasive, data-driven diagnostics in public health. This development underscored the company's innovative approach to addressing infectious disease detection challenges and signaled a shift towards more accessible and efficient diagnostic methods in the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is EDAS Healthcare's primary focus?
- EDAS Healthcare focuses on the instant detection of respiratory infectious diseases and COVID-19 using AI technology, aiming to improve treatment quality and reduce healthcare costs.
- When was EDAS Healthcare founded and by whom?
- EDAS Healthcare was founded in September 2018 by Guy Livne and Gal Almogy.
- What is EDAS Healthcare's total disclosed funding?
- EDAS Healthcare has raised a total of $60K in disclosed funding from one round. This funding includes a grant of $60K received from EU Horizon 2020 in February 2020.
- What significant grant did EDAS Healthcare receive?
- In February 2020, EDAS Healthcare received a grant of $60K from EU Horizon 2020.
- What was a key development for EDAS Healthcare in 2020?
- In September 2020, EDAS Healthcare's AI technology was noted for its capability to diagnose COVID-19 using patient demographics such as sex, age, and address.